Comparative Safety of Atorvastatin 80 mg Versus 10 mg Derived from Analysis of 49 Completed Trials in 14,236 Patients
Open Access
- 15 November 2005
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 97 (1), 61-67
- https://doi.org/10.1016/j.amjcard.2005.07.108
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinicsThe alliance studyJournal of the American College of Cardiology, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patientsThe American Journal of Cardiology, 2003
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Risk for Myopathy With Statin Therapy in High-Risk PatientsArchives of Internal Medicine, 2003
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988